Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer

Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PSA) were examined on 120 cases of stage D2 prostate cancer between 1979 and 1989. All patients received endocrine therapy as the first treatment; castration and immediate administration of estrogen or an...

Description complète

Détails bibliographiques
Publié dans:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 36(1990), 7 vom: 29. Juli, Seite 783-91
Auteur principal: Akimoto, S (Auteur)
Autres auteurs: Akakura, K, Masai, M, Isaka, S, Shimazaki, J
Format: Article
Langue:Japanese
Publié: 1990
Accès à la collection:Hinyokika kiyo. Acta urologica Japonica
Sujets:English Abstract Journal Article Androgen Antagonists Antigens, Neoplasm Biomarkers, Tumor Estrogens Prostatic Secretory Proteins Proteins Seminal Plasma Proteins beta-microseminoprotein plus... Gonadotropin-Releasing Hormone 33515-09-2 Acid Phosphatase EC 3.1.3.2 Prostate-Specific Antigen EC 3.4.21.77